GlassScriptPhysician profile
Mindy C Colgrove
NPI 1841601838
$575.12
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $38.33 · 2021: $47.81 · 2022: $142 · 2023: $105 · 2024: $47.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $267.47 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Myovant Sciences INC. | $48.53 | 2021-2022 | |
| Organon LLC | $46.76 | 2023-2024 | Nexplanon |
| Therapeuticsmd, INC. | $45.42 | 2019-2020 | |
| Coopersurgical, INC. | $31.46 | 2020-2024 | Paragard T 380a |
| Medtronic, INC. | $24.22 | 2021 | |
| Sumitomo Pharma America, INC. | $22.95 | 2023 | Myfembree |
| Astellas Pharma US INC | $19.73 | 2023 | Veozah |
| Scynexis, INC. | $15.87 | 2022 | |
| Vertical Pharmaceuticals, LLC | $15.04 | 2019 | |
| Exeltis, USA INC. | $13.42 | 2023 | Slynd |
| Merck Sharp & Dohme LLC | $12.81 | 2022 | |
| Allergan, INC. | $11.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mindy Colgrove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.